$United Therapeutics (UTHR.US)$Over the past 5 years, revenu...
$United Therapeutics(UTHR.US$Over the past 5 years, revenue has fluctuated around 1.6 billion yuan, with an overall slight decline in operating profit. Among them, there was a loss in 2019, and overall net profit fluctuated around 500 million, with the exception of the loss of 100 million in 2019.
In the first three quarters of 2022, revenue increased 13.7%. Operating profit doubled due to a sharp reduction in operating expenses, and net profit increased 64% to 600 million yuan.
Currently, the price-earnings ratio is 26 times, and the price-earnings ratio is 18 times TTM. If 2022 revenue reaches 800 million, corresponding to a price-earnings ratio of 15, it may not be high compared to the growth in the last 3 quarters, but there is still too little growth data at present, so you can watch a few more quarters before making a judgment.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
